Free press releases distribution network?

Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



KemTRACE® Brand Chromium Propionate is Now Available for Gilts and Sows in Canada - The Canadian Food Inspection Agency has permitted the use of KemTRACE® Chromium Propionate into breeding and lactating gilts and sows
KemTRACE® Brand Chromium Propionate is Now Available for Gilts and Sows in Canada

 

PRZOOM - /newswire/ - Des Moines, IA, United States, 2010/01/04 - The Canadian Food Inspection Agency has permitted the use of KemTRACE® Chromium Propionate into breeding and lactating gilts and sows.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Kemin Industries is pleased to announce the Canadian Food Inspection Agency (CFIA) is now permitting the use of KemTRACE® Chromium Propionate into breeding and lactating gilts and sows in Canada.

”Kemin is pleased to receive this additional product registration in Canada for KemTRACE Chromium Propionate,” says Cody Swan, product manager for Kemin Agrifoods. “KemTRACE Chromium Propionate is designed to provide swine producers with a powerful tool to maximize the nutritional value of feed.”

KemTRACE Chromium Propionate is a safe, highly bioavailable, and patented organic chromium source. Chromium propionate is intended to improve average daily gain when fed continuously from weaning to finishing, and is also used as a chromium supplement for breeding and lactating gilts and sows.

KemTRACE Chromium Propionate is available for use in growing and finishing Duroc swine in Canada. In the United States, chromium has been shown to affect insulin sensitivity and as a result promote glucose uptake; KemTRACE Chromium Propionate has been permitted in all phases of U.S. swine since 2000. It is also currently the only chromium source available for use in cattle in the United States.

Kemin® – Inspired Molecular Solutions™
Founded in 1961, the Kemin Group of Companies (kemin.com) provide health and nutritional solutions to the agrifood, food ingredients, pet food, human health and pharmaceutical industries. Kemin operates in more than 60 countries with manufacturing facilities in Belgium, Brazil, China, India, Singapore, South Africa, Thailand and the United States.

The AgriFoods businesses of Kemin focus on Total Nutrition™ to help customers achieve a highly effective, consistent system of profitable animal production. The essential combination of Kemin products with good nutrition and solid animal husbandry ensures that customers around the globe maintain profitability while enhancing the health and well being of animals.

KemTRACE® brand Chromium Propionate
KemTRACE Chromium Propionate contains chromium propionate, a patented product from Kemin Industries which provides a highly bioavailable organic source of chromium. Kemin is the exclusive source of chromium propionate. For more information, go to kemin.com/kemtracechromium.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


KemTRACE® Brand Chromium Propionate is Now Available for Gilts and Sows in Canada

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Erin Hockman 
515-559-5349 erin.hockman[.]kemin.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  SKS Media | SKS Associates Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today